Skip to content

    Recently Viewed

      Listening...

      Alex Gorsky

      Stories and features about the former Johnson & Johnson Chairman of the Board and CEO.
      Latest news
      Illustration of charts and graphs and a calculator

      What you need to know about Johnson & Johnson’s 2021 third-quarter earnings

      Check out this infographic breakdown of the company’s third-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Devices businesses.
      Latest news
      what-you-need-to-know-about-johnson-and-johnsons-2021-second-quarter-earnings-lede-0721.png

      What you need to know about Johnson & Johnson’s 2021 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.
      Latest news
      Lede-What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2021 first-quarter earnings

      Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
      Latest news
      lede-Johnson & Johnson Chairman and CEO Appears at the White House to Discuss the Company's Collaboration with Merck and Future Vaccine Production.jpg

      Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production

      Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
      Latest news
      lede-A Message from Chairman and CEO Alex Gorsky About Johnson & Johnson's Investigational COVID-19 Vaccine Candidate.jpg

      A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine

      The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.
      Latest news
      lede-What You Need to Know About Johnson & Johnson's 2020 Fourth-Quarter and Full-Year Earnings Report.png

      What you need to know about Johnson & Johnson’s 2020 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its consumer, pharmaceutical and medical devices businesses.
      Latest news
      Lede-What You Need to Know About Johnson & Johnson's 2020 Third-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2020 third-quarter earnings

      Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
      Latest news
      lede-What You Need to Know About Johnson & Johnson's 2020 Second-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2020 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
      Latest news
      lede-Chairman and CEO Alex Gorsky Discusses Johnson & Johnson's Response to COVID-19 at the Fortune Brainstorm Health Conference.jpg

      Chairman and CEO Alex Gorsky discusses Johnson & Johnson’s response to COVID-19 at the Fortune Brainstorm Health Conference

      Watch a video of Gorsky’s interview at the virtual summit, which includes the latest information on the company’s pursuit of a potential COVID-19 vaccine.
      Latest news
      lede-agletter-06-02-20.png

      A message from Johnson & Johnson Chairman and CEO Alex Gorsky about recent events in the United States

      In light of current events taking place across the country, our Chairman and CEO sent this letter to the company’s 135,000 global employees.